Skip to main content

Table 5 Sample analysis (n = 3)

From: Effective separation and simultaneous analysis of anabolic androgenic steroids (AAS) in their pharmaceutical formulations by a validated TLC-densitometry method

Brand name (sample code) Compounds detected Label claim (mg/injection) Amount detected (mg/injection)
(Mean ± S.D.)
% R.S.D. % Rec.
Testolic (S-1) TP 100 96.4 ± 0.53 0.56 96.4
Sustanon 250 (S-2) TP 30 27.15 ± 0.26 0.98 90.5
TPP 60 67.61 ± 0.41 0.62 112.6
TI 60 82.16 ± 0.55 0.68 136.9
TD 100 131.75 ± 1.97 1.50 131.7